
Ticavue 90mg Tablet
Marketer
Morepen Laboratories Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticavue 90mg Tablet
Among antiplatelet agents, Ticavue 90mg tablets work by inhibiting blood clot formation within blood vessels. This action helps prevent cardiac events, such as heart attacks and strokes, in individuals with pre-existing heart conditions. Furthermore, Ticavue 90mg is indicated for patients recovering from a heart attack or experiencing unstable angina following coronary stenting. Its use reduces the risk of recurrent cardiac events, including further heart attacks, strokes, and stent thrombosis. Concurrent use with aspirin, another antiplatelet medication, is typically prescribed. Ticavue 90mg tablets can be administered with or without food, consistently at the same time daily, for continuous efficacy. Discontinuation increases the risk of adverse cardiac events. The most frequent adverse effect is increased bleeding tendency; minor cuts or injuries may bleed longer than usual, though typically resolving spontaneously. Some patients may experience mild dyspnea, usually self-limiting with continued therapy. Persistent bleeding or worsening/unresolved dyspnea should be reported to a physician. Ticavue 90mg is contraindicated in patients with active bleeding (e.g., gastric ulcers, intracranial hemorrhage) or liver disease. Prior to initiating therapy, disclose any relevant medical history to your doctor.
Uses of Ticavue 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticavue 90mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 90mg Ticavue tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.
Common Side effects of Ticavue 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticavue 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 90mg Ticavue tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, however, consistent daily timing is recommended.
How Ticavue 90mg Tablet works:
To reduce the risk of stroke and heart attack, the antiplatelet drug Ticavue 90mg Tablet inhibits platelet aggregation, thus preventing the development of dangerous blood clots.
SAFETY ADVICE
AlcoholCAUTION
Using Ticavue 90mg tablets with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals may face risks when using Ticavue 90mg tablets. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticavue 90mg tablets with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticavue 90mg tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Ticavue 90mg tablets are considered safe. No dosage alteration is advised for Ticavue 90mg tablets. Data regarding the use of Ticavue 90mg tablets in patients undergoing renal dialysis is limited.
LiverCAUTION
Patients with hepatic impairment should use Ticavue 90mg Tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Ticavue 90mg Tablets are contraindicated in patients with severe liver dysfunction.
What if you forget to take Ticavue 90mg Tablet :
Should you forget to take a Ticavue 90mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticavue 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolo[1,5-a]pyrimidines |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
